Fig. 10From: Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisSubgroup analysis of risk of fractures with triple therapy vs. LAMA/LABA (a: Risk of fractures with triple therapy vs. LAMA/LABA based on duration; b: Risk of fractures with triple therapy vs. LAMA/LABA based on GOLD grade)Back to article page